- Home
- Publications
- Publication Search
- Publication Details
Title
Immunomodulation with IL-7 and IL-15 in HIV-1 infection
Authors
Keywords
-
Journal
Journal of Virus Eradication
Volume 9, Issue 3, Pages 100347
Publisher
Elsevier BV
Online
2023-09-05
DOI
10.1016/j.jve.2023.100347
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- IL-15 enhances HIV-1 infection by promoting survival and proliferation of CCR5+CD4+ T cells
- (2023) Yuhao Li et al. JCI Insight
- Safety and virologic impact of the IL-15 superagonist N-803 in people living with HIV: a phase 1 trial
- (2022) Jeffrey S. Miller et al. NATURE MEDICINE
- Harnessing cytokines and chemokines for cancer therapy
- (2022) David J. Propper et al. Nature Reviews Clinical Oncology
- Hematopoietic cell transplantation donor-derived memory-like NK cells functionally persist after transfer into patients with leukemia
- (2022) Melissa M. Berrien-Elliott et al. Science Translational Medicine
- Phase I Trial Characterizing the Pharmacokinetic Profile of N-803, a Chimeric IL-15 Superagonist, in Healthy Volunteers
- (2022) Mark P. Rubinstein et al. JOURNAL OF IMMUNOLOGY
- Heterogeneity of Latency Establishment in the Different Human CD4 + T Cell Subsets Stimulated with IL-15
- (2022) Giacomo M. Butta et al. JOURNAL OF VIROLOGY
- Early intervention with 3BNC117 and romidepsin at antiretroviral treatment initiation in people with HIV-1: a phase 1b/2a, randomized trial
- (2022) Jesper D. Gunst et al. NATURE MEDICINE
- Phase I Trial of N-803, an IL15 Receptor Agonist, with Rituximab in Patients with Indolent Non-Hodgkin Lymphoma
- (2021) Jennifer A. Foltz et al. CLINICAL CANCER RESEARCH
- Therapeutic Potential of IL-15 and N-803 in HIV/SIV Infection
- (2021) Olivia Harwood et al. Viruses-Basel
- Mathematical modeling of N-803 treatment in SIV-infected non-human primates
- (2021) Jonathan W. Cody et al. PLoS Computational Biology
- In Vivo Dynamics of the Latent Reservoir for HIV-1: New Insights and Implications for Cure
- (2021) Janet D. Siliciano et al. Annual Review of Pathology-Mechanisms of Disease
- Phase I study of single agent NIZ985, a recombinant heterodimeric IL-15 agonist, in adult patients with metastatic or unresectable solid tumors
- (2021) Kevin Conlon et al. Journal for ImmunoTherapy of Cancer
- Robust and persistent reactivation of SIV and HIV by N-803 and depletion of CD8+ cells
- (2020) Julia Bergild McBrien et al. NATURE
- IL‐7 induces sCD127 release and mCD127 downregulation in human CD8 + T cells by distinct yet overlapping mechanisms, both of which are impaired in HIV infection
- (2020) Sandra C. Côté et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- BCL-2 antagonism sensitizes cytotoxic T cell–resistant HIV reservoirs to elimination ex vivo
- (2020) Yanqin Ren et al. JOURNAL OF CLINICAL INVESTIGATION
- The human IL-15 superagonist N-803 promotes migration of virus-specific CD8+ T and NK cells to B cell follicles but does not reverse latency in ART-suppressed, SHIV-infected macaques
- (2020) Gabriela M. Webb et al. PLoS Pathogens
- Broadly neutralizing antibodies combined with latency-reversing agents or immune modulators as strategy for HIV-1 remission
- (2020) Jesper Damsgaard Gunst et al. Current Opinion in HIV and AIDS
- Interleukin 15 Pharmacokinetics and Consumption by a Dynamic Cytokine Sink
- (2020) John A. Hangasky et al. Frontiers in Immunology
- Reactivating latent HIV with PKC agonists induces resistance to apoptosis and is associated with phosphorylation and activation of BCL2
- (2020) Andrea J. French et al. PLoS Pathogens
- HIV-1 in lymph nodes is maintained by cellular proliferation during antiretroviral therapy
- (2019) William R. McManus et al. JOURNAL OF CLINICAL INVESTIGATION
- Immunotherapy in People With HIV and Cancer
- (2019) Camille E. Puronen et al. Frontiers in Immunology
- Vaccine-Induced Antibodies Mediate Higher Antibody-Dependent Cellular Cytotoxicity After Interleukin-15 Pretreatment of Natural Killer Effector Cells
- (2019) Leigh Fisher et al. Frontiers in Immunology
- First-in-human phase 1 clinical study of the IL-15 superagonist complex ALT-803 to treat relapse after transplantation
- (2018) Rizwan Romee et al. BLOOD
- Interleukin-15-Stimulated Natural Killer Cells Clear HIV-1-Infected Cells following Latency Reversal Ex Vivo
- (2018) Carolina Garrido et al. JOURNAL OF VIROLOGY
- ALT-803, an IL-15 superagonist, in combination with nivolumab in patients with metastatic non-small cell lung cancer: a non-randomised, open-label, phase 1b trial
- (2018) John M Wrangle et al. LANCET ONCOLOGY
- ALT-803 Transiently Reduces Simian Immunodeficiency Virus Replication in the Absence of Antiretroviral Treatment
- (2017) Amy L. Ellis-Connell et al. JOURNAL OF VIROLOGY
- Increased soluble IL-7 receptor concentrations associate with improved IL-7 therapy outcomes in SIV-infected ART-treated Rhesus macaques
- (2017) Amanda K. Steele et al. PLoS One
- Treatment intensification followed by interleukin-7 reactivates HIV without reducing total HIV DNA
- (2016) Christine Katlama et al. AIDS
- Intravaginal Administration of Fc-Fused IL7 Suppresses the Cervicovaginal Tumor by Recruiting HPV DNA Vaccine-Induced CD8 T Cells
- (2016) Y. W. Choi et al. CLINICAL CANCER RESEARCH
- Repeated Cycles of Recombinant Human Interleukin 7 in HIV-Infected Patients With Low CD4 T-Cell Reconstitution on Antiretroviral Therapy: Results of 2 Phase II Multicenter Studies
- (2016) Rodolphe Thiébaut et al. CLINICAL INFECTIOUS DISEASES
- The potential role for romidepsin as a component in early HIV-1 curative efforts
- (2016) Jesper Damsgaard Gunst et al. Expert Review of Anti-Infective Therapy
- IL-15 promotes activation and expansion of CD8+ T cells in HIV-1 infection
- (2016) Souheil-Antoine Younes et al. JOURNAL OF CLINICAL INVESTIGATION
- IL-7 Induces SAMHD1 Phosphorylation in CD4+ T Lymphocytes, Improving Early Steps of HIV-1 Life Cycle
- (2016) Mayte Coiras et al. Cell Reports
- A Subset of Latency-Reversing Agents Expose HIV-Infected Resting CD4+ T-Cells to Recognition by Cytotoxic T-Lymphocytes
- (2016) R. Brad Jones et al. PLoS Pathogens
- Interleukin-15 (IL-15) Strongly Correlates with Increasing HIV-1 Viremia and Markers of Inflammation
- (2016) Sanjay Swaminathan et al. PLoS One
- In VivoActivation of Human NK Cells by Treatment with an Interleukin-15 Superagonist Potently Inhibits AcuteIn VivoHIV-1 Infection in Humanized Mice
- (2015) Kieran Seay et al. JOURNAL OF VIROLOGY
- NK cells are primed by ANRS MVAHIV-infected DCs, via a mechanism involving NKG2D and membrane-bound IL-15, to control HIV-1 infection in CD4+T cells
- (2014) Uriel Y. Moreno-Nieves et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Therapeutic Vaccination with Simian Immunodeficiency Virus (SIV)-DNA+IL-12 or IL-15 Induces Distinct CD8 Memory Subsets in SIV-Infected Macaques
- (2014) R. Halwani et al. JOURNAL OF IMMUNOLOGY
- Increased IL-15 Production Is Associated with Higher Susceptibility of Memory CD4 T Cells to Simian Immunodeficiency Virus during Acute Infection
- (2014) M. D. Eberly et al. JOURNAL OF IMMUNOLOGY
- Histone Deacetylase Inhibitors Impair the Elimination of HIV-Infected Cells by Cytotoxic T-Lymphocytes
- (2014) Richard Brad Jones et al. PLoS Pathogens
- Interleukin-7 promotes HIV persistence during antiretroviral therapy
- (2013) C. Vandergeeten et al. BLOOD
- Effects of Recombinant Human Interleukin 7 on T-Cell Recovery and Thymic Output in HIV-Infected Patients Receiving Antiretroviral Therapy: Results of a Phase I/IIa Randomized, Placebo-Controlled, Multicenter Study
- (2012) Y. Lévy et al. CLINICAL INFECTIOUS DISEASES
- Safety and Immunogenicity of an HIV-1 Gag DNA Vaccine with or without IL-12 and/or IL-15 Plasmid Cytokine Adjuvant in Healthy, HIV-1 Uninfected Adults
- (2012) Spyros A. Kalams et al. PLoS One
- Expression of Interleukin-15 and Interleukin-15Rα in Monocytes of HIV Type 1-Infected Patients with Different Courses of Disease Progression
- (2011) Maciej Tarkowski et al. AIDS RESEARCH AND HUMAN RETROVIRUSES
- Safety (toxicity), pharmacokinetics, immunogenicity, and impact on elements of the normal immune system of recombinant human IL-15 in rhesus macaques
- (2011) T. A. Waldmann et al. BLOOD
- IL-15 delays suppression and fails to promote immune reconstitution in virally suppressed chronically SIV-infected macaques
- (2011) E. Lugli et al. BLOOD
- TLR agonists and/or IL-15 adjuvanted mucosal SIV vaccine reduced gut CD4+ memory T cell loss in SIVmac251-challenged rhesus macaques
- (2011) Yongjun Sui et al. VACCINE
- Homeostatic Proliferation Fails to Efficiently Reactivate HIV-1 Latently Infected Central Memory CD4+ T Cells
- (2011) Alberto Bosque et al. PLoS Pathogens
- HIV-1 viruses detected during episodic blips following interleukin-7 administration are similar to the viruses present before and after interleukin-7 therapy
- (2010) Hiromi Imamichi et al. AIDS
- Interleukin-7 treatment counteracts IFN- therapy-induced lymphopenia and stimulates SIV-specific cytotoxic T lymphocyte responses in SIV-infected rhesus macaques
- (2010) R. Parker et al. BLOOD
- Transient and persistent effects of IL-15 on lymphocyte homeostasis in nonhuman primates
- (2010) E. Lugli et al. BLOOD
- Increased CD4+ T Cell Levels during IL-7 Administration of Antiretroviral Therapy-Treated Simian Immunodeficiency Virus-Positive Macaques Are Not Dependent on Strong Proliferative Responses
- (2010) A. Leone et al. JOURNAL OF IMMUNOLOGY
- Innate and adaptive immune correlates of vaccine and adjuvant-induced control of mucosal transmission of SIV in macaques
- (2010) Y. Sui et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Safety and immunologic effects of IL-15 administration in nonhuman primates
- (2009) C. Berger et al. BLOOD
- IL-7 administration drives T cell-cycle entry and expansion in HIV-1 infection
- (2009) I. Sereti et al. BLOOD
- Novel Human Interleukin-15 Agonists
- (2009) X. Zhu et al. JOURNAL OF IMMUNOLOGY
- HIV reservoir size and persistence are driven by T cell survival and homeostatic proliferation
- (2009) Nicolas Chomont et al. NATURE MEDICINE
- Down‐Regulation of Interleukin‐7 Receptor (CD127) in HIV Infection Is Associated with T Cell Activation and Is a Main Factor Influencing Restoration of CD4+Cells after Antiretroviral Therapy
- (2008) José M. Benito et al. JOURNAL OF INFECTIOUS DISEASES
- Relationship between T Cell Activation and CD4+T Cell Count in HIV‐Seropositive Individuals with Undetectable Plasma HIV RNA Levels in the Absence of Therapy
- (2007) Peter W. Hunt et al. JOURNAL OF INFECTIOUS DISEASES
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now